Latest news for IPH (OTC:IPHLF) Stock

IPH Ltd provides intellectual property services and data analytics software development services. The company's intellectual property services, which is provided through the company's subsidiaries Spruson and Ferguson, Fisher Adams, Kelly Callinans, Pizzeys and Cullens, involve patents filing, prosecution, enforcement and management, designing, trademarks, and others. The company's intellectual property software business, which is operated under a subscription license model, is carried out through the company's subsidiary Practice Insight. The company generates the majority of its revenue from Australia & New Zealand.

IPH Ltd

First American Financial (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/faf#NYSE">FAF</a>) reports a second-quarter 2024 operating income per share of $1.27, which beat the Zacks Consensus Estimate by 12.4%. The bottom line decreased 5.9% year over year.
The insurer&#39;s results reflect the benefits of the seasonal pick-up in demand despite challenging market conditions.
<h3>Behind the Headlines</h3>
Operating revenues of $1.6 billion dropped 2.1% year over year due to lower agent premiums and information and other. The top line missed the Zacks Consensus Estimate by 1.2%.
<div class="chart_embed">
<h3>First American Financial Corporation Price, Consensus and EPS Surprise</h3>
<img alt="First American Financial Corporation Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/11/1721923696.png" style="height:265px; width:574px" title="" />
First American Financial Corporation price-consensus-eps-surprise-chart | First American Financial Corporation Quote
Investment income was $129.9 million in the first quarter, declining 4.5% year over year. The figure was lower than our estimate of $150 million.
Expenses inched down 0.9% to $1.5 billion. Our estimate was $1.5 billion.
</div>
<h3>Segment Results</h3>
Title Insurance and Services: Total revenues fell 0.6% year over year to $1.5 billion. The downside was due to lower agent premiums and information and other. The figure was in line with our estimate.&nbsp;
Investment income of $126 million declined 11.3% year over year. The downside was primarily due to lower average interest-bearing escrow and tax-deferred property exchange balances, partly offset by higher interest income from the company&#39;s warehouse lending business.
Adjusted pretax margin contracted 70 basis points (bps) year over year to 11.9%. Title open orders dropped 2.8% to 169,600. Title closed orders fell 2.8% to 124,700. The average revenue per direct title order increased 0.9% to $11,700, primarily owing to a shift in the mix from lower premium default transactions to higher premium commercial transactions and an increase in the average revenue per order for purchase transactions.
Home Warranty: Total revenues increased 0.3% to $106 million. The figure was higher than our estimate of $102.6 million. Pretax income of $16.5 million increased 15.4% year over year. The claim loss rate was 45.8% in the first quarter, contracting 340 bps due to lower claim severity, which was partially offset by higher claim frequency. The pretax margin was 15.4%, which expanded 200 bps year over year.
Corporate: Net investment income was $4 million, down 50% year over year, primarily attributable to changes in the value of investments associated with the company&#39;s deferred compensation program. This amount was offset by lower personnel expenses reflecting returns on the plan participants&#39; investments.
Interest expenses were $23 million, up 9% year over year due to higher interest expenses in the company&#39;s warehouse lending business.
<h3>Financial Update</h3>
First American exited the quarter with cash and cash equivalents of $2 billion, down 43.2% from the end of 2023. Notes and contracts payable were $1.4 billion, up 0.4% from the end of 2023.
Stockholders&#39; equity was $4.7 billion, down 0.7% from the 2023-end level. The debt-to-capital ratio was 29.7.
FAF bought back shares worth $4 1million in the quarter. Through Jul 23, it repurchased an additional $15 million worth of shares.
Cash flow from operations was $267 million, down 0.7% year over year.
<h3>Zacks Rank</h3>
FAF currently carries a Zacks Rank #3 (Hold).
<h3>Performance of Other Insurers</h3>
The Travelers Companies (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trv#NYSE">TRV</a>) reported a second-quarter 2024 core income of $2.51 per share, which beat the Zacks Consensus Estimate by 25.5%. The bottom line skyrocketed from 6 cents in the year-ago quarter, driven by solid underlying results, net favorable prior-year reserve development and higher net investment income, partially offset by higher catastrophe losses. Travelers&#39; total revenues increased 12.4% from the year-ago quarter&#39;s figure to $11.3 billion, primarily driven by higher premiums. The top-line figure missed the Zacks Consensus Estimate by 1%.
Net written premiums increased 8% year over year to a record $11.1 billion, driven by strong growth across all three segments. The figure was higher than our estimate of $10.4 billion. Travelers witnessed an underwriting loss of $65 million, narrower than a loss of $640 million incurred in the year-ago quarter. The combined ratio improved 630 bps year over year to 100.2 due to an improvement in the underlying combined ratio, higher net favorable prior-year reserve development and lower catastrophe losses, as a percentage of net earned premiums. The Zacks Consensus Estimate was pegged at 97.
The Progressive Corporation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pgr#NYSE">PGR</a>) second-quarter 2024 earnings per share of $2.65 beat the Zacks Consensus Estimate of $1.99. The bottom line improved more than five times year over year. Operating revenues of $18.3 billion beat the Zacks Consensus Estimate by 1.4% and increased 18.9% year over year.
Net premiums earned grew 19% to $17.2 billion and beat our estimate of $16.7 billion. The combined ratio improved by 850 bps from the prior-year quarter&#39;s level to 91.9.
Selective Insurance Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sigi#NASDAQ">SIGI</a>) reported a second-quarter 2024 operating loss of $1.10 per share against the Zacks Consensus Estimate for earnings of $1.56. The company reported an operating income of 99 cents per share in the prior-year quarter. The quarterly results reflected poor underwriting performance, unfavorable prior-year casualty reserve development and escalating costs, offset by higher premiums and net investment income.
Total revenues of $1.2 billion increased 15% from the year-ago quarter&#39;s figure, primarily due to higher premiums earned, net investment income and net premiums written. The top line missed the Zacks Consensus Estimate by 1.3%.
<a href="https://www.zacks.com/stock/news/2309346/first-american-faf-q2-earnings-top-revenues-miss-estimates?cid=CS-BENZ-FT-analyst_blog|earnings_article-2309346">To read this article on Zacks.com click here.</a>

Earnings

News

Markets

Analyst Ratings

Trading Ideas

SIGI

First American Q2 Earnings Top, Revenues Miss Estimates

Earnings Beats

Earnings Misses

CINF

Cincinnati Financial Q2 2024 Adj Sales $2.407B Miss $2.449B Estimate

Dividends

Principal Financial Increases Dividend From $0.71 To $0.72 Per Share

Princeton Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPRN#NASDAQ">BPRN</a>) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.69 by 15.94 percent. This is a 25.23 percent decrease over earnings of $1.07 per share from the same period last year. The company reported quarterly sales of $20.62 million which beat the analyst consensus estimate of $15.86 million by 29.99 percent. This is a 24.27 percent decrease over sales of $27.23 million the same period last year.

BPRN

Princeton Bancorp Q2 EPS $0.80 Beats $0.69 Estimate, Sales $20.62M Beat $15.86M Estimate

Hovde Group analyst David Bishop downgrades Renasant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNST#NYSE">RNST</a>) from Outperform to Market Perform and announces $38 price target.

Downgrades

Price Target

RNST

Hovde Group Downgrades Renasant to Market Perform, Announces $38 Price Target

VeriSign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>) reported quarterly earnings of $2.01 per share which beat the analyst consensus estimate of $1.93 by 4.15 percent. This is a 12.29 percent increase over earnings of $1.79 per share from the same period last year. The company reported quarterly sales of $387.10 million which beat the analyst consensus estimate of $385.80 million by 0.34 percent. This is a 4.06 percent increase over sales of $372.00 million the same period last year.

VRSN

VeriSign Q2 EPS $2.01 Beats $1.93 Estimate, Sales $387.10M Beat $385.80M Estimate

Tivic Health Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) shares are climbing Thursday on heavy trading volume. The company recently announced three new<a href="https://www.benzinga.com/pressreleases/24/07/b39908008/tivic-health-expands-intellectual-property-portfolio"> patents in the U.S. and Europe.&nbsp;</a>
What To Know:
Tivic Health's stock is one of the top trending tickers on Yahoo Finance as retail investors pile into the health technology company's stock. According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, more than 65 million shares have been traded in Thursday's session, compared to the stock's float of just over 6 million shares.&nbsp;
Tivic Health announced on Tuesday it has received patent grants from the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) both titled &#8220;Adaptive Trigger For a Microcurrent Stimulation Device&#8221; and a patent entitled &#8220;Sinus Treatment Device With Adaptive Circuit&#8221; from the EPO.&nbsp;
Read Next:<a href="https://www.benzinga.com/news/earnings/24/07/39944935/quantumscape-stock-falls-on-q2-results-heres-why"> QuantumScape Stock Falls On Q2 Results: Here&#8217;s Why</a>
The company is focused on developing and commercializing non-invasive bioelectronic medicine. ClearUP Sinus Relief is Tivic Health's patented handheld device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Tivic Health shares are trading below the stock&#8217;s 50-day moving average of 40 cents and near its 52-week low of 28 cents.&nbsp;
<h2 class="wp-block-heading">How To Buy TIVC Stock:</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Tivic Health Systems&#8217; case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
TIVC Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Tivic Health shares finished 34.8% higher at 41 cents on Thursday.
Read Also:
<ul id="block-ecb36010-77ff-4a35-9019-dfce231e93a6">
<li><a href="https://www.benzinga.com/general/biotech/24/07/39944467/viking-therapeutics-stock-climbs-on-q2-eps-beat">Viking Therapeutics Stock Climbs On Q2 EPS Beat $VKTX</a></li>
</ul>
Image: PublicDomainPictures from Pixabay

Penny Stocks

Health Care

After-Hours Center

Movers

TIVC

What's Going On With Tivic Health Stock?

Principal Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>) reported quarterly earnings of $1.63 per share which missed the analyst consensus estimate of $1.85 by 11.89 percent.

Principal Finl Gr Q2 2024 Adj EPS $1.63 Misses $1.85 Estimate

Boston Beer Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>) reported quarterly earnings of $4.39 per share which missed the analyst consensus estimate of $5.10 by 13.92 percent. The company reported quarterly sales of $579.100 million which missed the analyst consensus estimate of $597.333 million by 3.05 percent. This is a 4.01 percent decrease over sales of $603.304 million the same period last year.

Boston Beer Co Q2 2024 GAAP EPS $4.39 Misses $5.10 Estimate, Sales $579.100M Miss $597.333M Estimate

<a href="https://www.globenewswire.com/Tracker?data=i0n_G8_JBxbl_zvVP9SE6wkC0C5QIscY93nJEtAqolIJ0FiOQGaTfpWUqtEKpHZjC4vy6pD88N9CKR44DKWJ5VIFZ29_bYTZPuYy4XmyoHcczZHNAZtJODGdi7accdM5">Phillips Edison &amp; Company, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PECO#NASDAQ">PECO</a>) ("PECO"), one of the nation's largest owners and operators of grocery-anchored neighborhood shopping centers, today announced its acquisition of Des Peres Corners, a grocery-anchored shopping center in Des Peres, Missouri, with Cohen &amp; Steers Income Opportunities REIT, Inc. ("CNSREIT"). The acquisition was made through a programmatic joint venture targeting $300 million in equity and owned 80% by CNSREIT and 20% by PECO. The joint venture will focus on acquiring open-air, grocery-anchored shopping centers and will leverage PECO's deep sector expertise.

PECO

Phillips Edison & Company Acquires Grocery-Anchored Shopping Center In Partnership With Cohen & Steers Income Opportunities REIT; The Acquisition Was Made Through A Programmatic Joint Venture Targeting $300M In Equity And Owned 80% By CNSREIT And 20% By PECO

Juniper Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNPR#NYSE">JNPR</a>) reported quarterly earnings of $0.31 per share which missed the analyst consensus estimate of $0.44 by 29.55 percent. The company reported quarterly sales of $1.19 billion which missed the analyst consensus estimate of $1.25 billion by 4.96 percent. This is a 16.78 percent decrease over sales of $1.43 billion the same period last year.

JNPR

Juniper Networks Q2 2024 Adj EPS $0.31 Misses $0.44 Estimate, Sales $1.19B Miss $1.25B Estimate

Cousins initial commitment is&nbsp;$27.2 million&nbsp;with a potential total commitment of&nbsp;$37.0 million. The loans have initial maturity dates of&nbsp;June 2025&nbsp;and&nbsp;February 2026&nbsp;and carry a current weighted average interest rate of&nbsp;SOFR plus 866 basis points.

Cousins Properties Acquires Two Newly-created Mezzanine Loans From The Existing Lender

FedEx's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) short percent of float has risen 8.48% since its last report. The company recently reported that it has 4.01 million shares sold short, which is 1.79% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.4 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>FedEx Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721938520_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for FedEx has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing FedEx's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, FedEx's peer group average for short interest as a percentage of float is 4.32%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About FedEx?

Investors are increasingly bullish on small-cap stocks, driven by optimistic projections for the interest-rate-sensitive segment of the market to thrive as the market approaches the onset of a <a href="https://www.benzinga.com/topic/interest-rates">Federal Reserve rate cut cycle.</a>
July has been a pivotal month, as small caps significantly outperformed large caps, especially in the tech sector, which dominated during the nearly two-year bull market.
The Russell 2000 index has surged nearly 9% month-to-date compared to a 3.6% decline for the tech-heavy Nasdaq 100 as of July 25.
The performance gap of nearly 13 percentage points in favor of the Russell 2000 over tech marks the best month for the &#8220;long small cap, short tech&#8221; trade since April 2002, highlighting the strength and speed of the ongoing market rotation.
<h3 class="wp-block-heading">Chart: It&#8217;s The Best Month In Over 2 Decades For The &#8216;Long Russell 2000, Short Nasdaq 100&#8217; Trade</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="487" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/25153006/image-43-1024x487.png" alt="" class="wp-image-457807" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/25153006/image-43-1024x487.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/25153006/image-43-300x143.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/25153006/image-43-768x365.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/25153006/image-43-1536x730.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/07/25153006/image-43.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">Strong Inflows Into Small-Cap ETFs</h3>
The impressive performance of small-cap stocks has been mirrored by significant inflows into major small-cap-focused ETFs. 
The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>), one of the largest ETFs tracking the U.S. small-cap index, saw over $6 billion in net inflows this month, marking the highest influx of 2024 to date, according to data from Etfdb.com.
Several other small-cap ETFs have also drawn considerable investor funds this month:
<ul>
<li>iShares Core S&amp;P Small-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IJR#NYSE">IJR</a>): $645 million in net inflows</li>
<li>Avantis U.S. Small Cap Value ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVUV#NYSE">AVUV</a>): $553.28 million in net inflows</li>
<li>Invesco S&amp;P SmallCap Momentum ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XSMO#NYSE">XSMO</a>): $350 million in net inflows</li>
<li>SPDR Portfolio S&amp;P 600 Small Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPSM#NYSE">SPSM</a>): $188 million in net inflows</li>
</ul>
Year-to-date, the Vanguard Small-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VB#NYSE">VB</a>) and the Pacer US Small Cap Cash Cows 100 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALF#NYSE">CALF</a>) have attracted the most investor money, with $3.1 billion and $2.9 billion, respectively.
<h3 class="wp-block-heading">A Different Perspective</h3>
Despite the strong performance of the Russell 2000 index and the substantial inflows into small-cap ETFs, some experts urge caution.
&#8220;Investors and analysts are hopeful that the end of the Federal Reserve's tightening cycle will bring better days for smaller companies, particularly those that rely on debt to fund operations. We're not convinced,&#8221; said veteran Wall Street investor Ed Yardeni in a note.
Larger companies, especially in the technology sector, possess advantages that smaller firms cannot easily replicate, he said. 
For instance, major tech firms are sitting on significant cash reserves, enabling them to fund substantial capital expenditures and R&amp;D budgets, maintaining their competitive edge.
To give some examples, Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) sits on a stockpile of cash equalling $111 billion at the end of last quarter. Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>) have cash reserves of $87 billion and $80 billion, respectively.
Their financial flexibility allows for strategic acquisitions of smaller companies with important new technology or business lines. Microsoft&#8217;s $10-billion investment in OpenAI, the developer of ChatGPT, last year exemplifies this capability.
Yardeni suggests the fastest-growing, highest-potential companies may have already partnered with large-cap firms or private equity investors.
&#8220;That, of course, implies that the laggards are left to trade in the S&amp;P 400 and S&amp;P 600—suggesting that investors will return to larger-cap alternatives sooner rather than later,&#8221; he said.
Read Now:
<ul>
<li><a href="https://www.benzinga.com/government/24/07/39867425/contrarian-analyst-turns-to-bonds-ahead-of-fed-rate-cuts-presidential-election-maybe-tariffs-deflati">Contrarian Analyst Turns To Bonds Ahead Of Fed Rate Cuts, Presidential Election: &#8216;Maybe Tariffs Deflationary Not Inflationary&#8217;</a></li>
</ul>
Photo created using artificial intelligence via MidJourney.

Equities

Large Cap

Macro Economic Events

Sector ETFs

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

Tech

ETFs

AMZN

AVUV

CALF

GOOGL

MSFT

SPSM

XSMO

Investors Go All In On Small Caps, Pour Over $6 Billion Into Russell 2000 ETF This Month: They 'Will Return To Larger-Cap Alternatives,' Veteran Analyst Says

NetApp's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTAP#NYSE">NTAP</a>) short percent of float has risen 11.76% since its last report. The company recently reported that it has 5.71 million shares sold short, which is 3.23% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.22 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>NetApp Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721938515_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for NetApp has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing NetApp's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, NetApp's peer group average for short interest as a percentage of float is 6.35%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

NTAP

Peering Into NetApp's Recent Short Interest

Sangamo Therapeutics's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NYSE">SGMO</a>) short percent of float has fallen 17.95% since its last report. The company recently reported that it has 12.73 million shares sold short, which is 6.17% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.18 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Sangamo Therapeutics Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721938510_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Sangamo Therapeutics has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Sangamo Therapeutics's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Sangamo Therapeutics's peer group average for short interest as a percentage of float is 7.09%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

SGMO

Peering Into Sangamo Therapeutics's Recent Short Interest

WSFS Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSFS#NASDAQ">WSFS</a>) reported quarterly earnings of $3.97 per share which beat the analyst consensus estimate of $1.04 by 281.73 percent. The company reported quarterly sales of $384.60 million which beat the analyst consensus estimate of $174.91 million by 119.89 percent. This is a 111.50 percent increase over sales of $181.84 million the same period last year.

WSFS

WSFS Financial Q2 2024 Adj EPS $3.97 Beats $1.04 Estimate, Sales $384.60M Beat $174.91M Estimate

Mohawk Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>) reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.75 by 9.09 percent. This is a 8.7 percent increase over earnings of $2.76 per share from the same period last year. The company reported quarterly sales of $2.80 billion which missed the analyst consensus estimate of $2.83 billion by 1.02 percent. This is a 5.05 percent decrease over sales of $2.95 billion the same period last year.

Mohawk Industries Q2 Adj $3.00 Beats $2.75 Estimate, Sales $2.80B Miss $2.83B Estimate

Guidance

L3Harris Technologies Raises FY24 EPS Guidance From $12.70-$13.05 To $12.85-$13.15 Vs $12.97 Est.; Revenue Guidance From $20.8B-$21.3B To $21B-$21.3B Vs $21.21B Est.

BTIG analyst Mark Massaro initiates coverage on IDEXX Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDXX#NASDAQ">IDXX</a>) with a Buy rating and announces Price Target of $580.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

IPH

News

Latest news for IPH (OTC:IPHLF) Stock